In addition, β-Klotho activation may also affect the occurrence and progression of diabetic complications, such as reducing cholesterol synthesis and fat deposition in the liver and improving non-alcoholic fatty liver disease. This evidence concerns the gene KLB and metabolic dysfunction-associated steatotic liver disease.